JoAnn V Pinkerton Selected Research

bazedoxifene

12/2021	Selective Estrogen Receptor Modulators in Gynecology Practice.
12/2017	Time to first occurrence of breast pain and vaginal bleeding in phase 3 trials of CE/BZA.
6/2017	Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
11/2016	Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Vasomotor Symptoms in the Selective Estrogens, Menopause, and Response to Therapy Trials.
10/2016	Most bothersome symptom in women with genitourinary syndrome of menopause as a moderator of treatment effects.
5/2016	Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials.
1/2016	Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trials.
7/2015	Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence.
7/2014	Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.
9/2011	Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

JoAnn V Pinkerton Research Topics

Disease

15	Breast Neoplasms (Breast Cancer) 12/2021 - 03/2010
11	Atrophy 01/2018 - 05/2002
10	Osteoporosis 12/2021 - 05/2008
6	Dyspareunia 12/2021 - 01/2015
6	Hot Flashes 11/2016 - 07/2009
6	Endometrial Hyperplasia 05/2016 - 11/2009
5	Postmenopausal Osteoporosis 10/2016 - 11/2009
4	Endometrial Neoplasms (Endometrial Cancer) 12/2017 - 11/2009
4	Uterine Hemorrhage (Uterine Bleeding) 12/2017 - 05/2010
3	Amenorrhea 12/2021 - 03/2006
3	Coronary Disease (Coronary Heart Disease) 01/2020 - 09/2011
3	Neoplasms (Cancer) 01/2018 - 11/2009
2	Chronic Disease (Chronic Diseases) 01/2020 - 01/2018
2	Mastodynia 12/2017 - 05/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 08/2010
2	Ovarian Cysts (Ovarian Cyst) 05/2016 - 11/2009
2	Hemorrhage 07/2015 - 04/2011
2	Metrorrhagia (Spotting) 07/2015 - 04/2011
2	Osteoporotic Fractures 08/2010 - 03/2010
2	Polyps 05/2010 - 11/2009
1	Hypersensitivity (Allergy) 05/2022
1	Psychological Sexual Dysfunctions (Sexual Arousal Disorder) 01/2021
1	Frailty 01/2020
1	Sarcopenia 01/2020
1	Confusion (Bewilderment) 01/2019
1	Triple Negative Breast Neoplasms 01/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018
1	Urinary Tract Infections (Urinary Tract Infection) 01/2018
1	Sleep Wake Disorders 10/2017
1	Metabolic Bone Diseases (Osteopenia) 10/2017
1	Meningitis 02/2016
1	Dementia (Dementias) 11/2015
1	Adenocarcinoma 09/2011
1	Pulmonary Embolism 09/2011
1	Stroke (Strokes) 09/2011
1	Dysmenorrhea (Menstrual Pain) 04/2011
1	Ovarian Neoplasms (Ovarian Cancer) 04/2011
1	Thrombosis (Thrombus) 04/2011
1	von Willebrand Diseases (von Willebrand's Disease) 04/2011
1	Mood Disorders (Mood Disorder) 08/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2010
1	Gastroesophageal Reflux (GERD) 03/2010
1	Celiac Disease (Celiac Sprue) 03/2010
1	Anemia 03/2010
1	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 11/2009
1	Urinary Incontinence 05/2008
1	Primary Ovarian Insufficiency 03/2006

Drug/Important Bio-Agent (IBA)

14	Estrogens (Estrogen)FDA Link 12/2021 - 05/2002
13	bazedoxifeneIBA 12/2021 - 11/2009
11	Conjugated (USP) Estrogens (Premarin)FDA Link 12/2021 - 04/2011
11	Hormones (Hormone)IBA 01/2021 - 05/2008
6	Raloxifene Hydrochloride (Evista)FDA Link 12/2021 - 01/2003
4	OspemifeneIBA 12/2021 - 01/2015
4	Progestins (Progestagens)IBA 01/2020 - 07/2010
3	Tamoxifen FDA LinkGeneric 12/2021 - 05/2010
3	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2020 - 05/2016
3	mahuang-tangIBA 01/2020 - 07/2010
2	LasofoxifeneIBA 12/2021 - 05/2010
2	Testosterone (Sustanon)FDA Link 01/2021 - 01/2018
2	Dehydroepiandrosterone (DHEA)IBA 01/2018 - 10/2017
2	Aromatase InhibitorsIBA 01/2018 - 10/2017
2	Estrogen ReceptorsIBA 01/2018 - 01/2015
2	Selective Estrogen Receptor Modulators (SERM)IBA 05/2010 - 11/2009
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2003 - 05/2002
1	AndrogensIBA 01/2018
1	tiboloneIBA 10/2017
1	SteroidsIBA 02/2016
1	salicylhydroxamic acid (SHAM)IBA 08/2014
1	Gabapentin (Neurontin)FDA LinkGeneric 06/2014
1	Desvenlafaxine Succinate FDA Link 01/2013
1	Tranexamic Acid (AMCA)FDA Link 04/2011
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2011
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 04/2011
1	Oral ContraceptivesIBA 04/2011
1	Danazol (Azol)FDA LinkGeneric 04/2011
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 04/2011
1	Plasminogen Activators (Plasminogen Activator)IBA 04/2011
1	ProstaglandinsIBA 04/2011
1	LY 353381 (LY353381)IBA 05/2010
1	Vitamin D FDA LinkGeneric 03/2010
1	IronIBA 03/2010
1	Immunoglobulin A (IgA)IBA 03/2010
1	Protein Glutamine gamma Glutamyltransferase 2IBA 03/2010
1	LipidsIBA 05/2008
1	Follicle Stimulating Hormone (Follitropin)FDA Link 03/2006
1	Dihydrotachysterol (AT 10)IBA 01/2003

Therapy/Procedure

20	Therapeutics 05/2022 - 05/2008
2	Injections 02/2016 - 04/2011
1	Lasers (Laser) 01/2019
1	Hormonal Contraception 01/2018
1	Contraception (Birth Control) 04/2011
1	Intrauterine Devices (Intrauterine Device) 04/2011
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 03/2010
1	Female Contraceptive Devices (Vaginal Ring) 01/2003